State Council defines concentrations of business operators of the pharmaceutical sector. Network trading platform operators are required to submit information on the identities of online trading ...
Philip Qu of TransAsia Lawyers analyze regulatory and statutory progress in China’s ever flourishing TMT sector in 2024, and look at the outlook for 2025 ...
Trump signs memorandum to restrict investments that do not serve American interests; A Jiangsu court ruled that investments ...
China’s intellectual property law space. [Danlei Wu] of [Fangda Partners] examines the key developments and the indicators for further developments in the year ahead ...
Chinese regulatory support to China originated-biopharma companies is going global. Wu Ting, partner of the Life Sciences and Healthcare Practice at Haiwen & Partners examines the implications ...
Casper Sek of Jingtian & Gongcheng examines the evolution and refinement of China’s data protection oversight throughout 2024 ...
Simon Leung, Partner of Baker McKenzie, and Terry Xu, Senior Counsel at FenXun Partners, examine key regulatory shifts in 2024 and provide an outlook of potential regulatory trends for the banking and ...
Major Chinese EV maker Geely has signed a deal with Renault to produce cars in Brazil following rival BYD’s expansion into the South American nation, SCMP reports. The deal does not officially name ...
China Law & Practice Awards 2024 sees a broad spectrum of law firms seize crown in individual practices. Fangda Partners and Clifford Chance win top accolades in the 18th annual CLP Awards. Clifford ...
Casper Sek and Alan Zhang of Jingtian & Gongcheng provide answers to key questions on China’s data transfer regime, and identify some vital trends “There are typically no specific restrictions on the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results